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Plasma membrane-derived extracellular vesicles (EV) are released for most cells types and are 
important mediators of intercellular communication. In the context of cancer, EVs mediate the 
intercellular transfer of deleterious traits including multidrug resistance (MDR), enhanced 
metastatic capacity, evasion of immune surveillance, and altered tissue biomechanics. The 
biogenesis of plasma membrane EVs is characterised by an increase in intracellular calcium 
followed by successive membrane and cytoskeletal changes. However, the precise biogenic 
mediators and differences between malignant and non-malignant plasma membrane-derived 
EV biogenesis remain undefined. Uncovering discrete pathways of biogenesis in malignant 
and non-malignant cells holds potential in the search for new strategies to circumvent the 
acquisition and transfer of plasma membrane EV-meditated deleterious traits in cancer. 
In this thesis, the molecular pathways that regulate plasma membrane EV biogenesis in 
malignant and non-malignant cells are investigated. 
This study evidences that discrete EV biogenic pathways exist in malignant and non-malignant 
cells. At rest, biogenesis of cancer EVs is regulated by a calcium-calpain dependent pathway 
whereas non-malignant biogenesis is driven by alternative pathways. Comparing the surface 
topography of malignant and non-malignant cells using atomic force microscopy demonstrates 
malignant cells have intrinsically higher vesiculation at rest and this is shown to be driven by 
high basal calcium mobilisation. Interrogating the calcium signalling pathways that regulate 
biogenesis with pharmacological modulators of calcium revealed increases in free cytosolic 
Ca2+ via endoplasmic reticulum (ER) Ca2+ store depletion with thapsigargin increases EV 
biogenesis in both malignant and non-malignant cells. Evidencing a role for the ER in plasma 
membrane EV biogenesis for the first time. Furthermore, the store-operated calcium entry 
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(SOCE) plays an essential role in the maintenance of plasma membrane EV biogenesis after 
store depletion.  
The calcium-calpain pathway is also a known regulator of αII-spectrin structural dynamics and 
this work evidences that it plays a role in increased vesiculation in malignant cells. High 
resolution confocal microscopy in combination with a custom designed, automated image 
analysis plugin, provided an unbiased platform to show that the subcellular localisation of 
spectrin is distinctly different in malignant and non-malignant cells at rest. Non-malignant cells 
display prominent αII-spectrin borders and are low vesiculators. It is the redistribution of αII-
spectrin from the membrane to the cytoplasm that drives plasma membrane-derived EV 
biogenesis in malignant cells. 
These findings provide new insight into the biogenic pathways regulating EV biogenesis in 
both malignant and non-malignant cells and identifies strategies for the selective modulation 
of plasma membrane EV biogenesis in malignancy. 
 
  
